フォロー
Marc S. Sabatine
Marc S. Sabatine
TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School
確認したメール アドレス: partners.org
タイトル
引用先
引用先
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
245912017
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
164392014
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on …
RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin III, ...
Circulation 129 (23), e521-e643, 2014
9314*2014
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
79482020
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
DC Goff Jr, DM Lloyd-Jones, G Bennett, S Coady, RB D’agostino, ...
Circulation 129 (25_suppl_2), S49-S73, 2014
68952014
2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association …
EA Amsterdam, NK Wenger, RG Brindis, DE Casey, TG Ganiats, ...
Journal of the American College of Cardiology 64 (24), e139-e228, 2014
6181*2014
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ...
New England Journal of Medicine 380 (4), 347-357, 2019
56292019
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
55312019
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England journal of medicine 376 (18), 1713-1722, 2017
55172017
Cytochrome p-450 polymorphisms and response to clopidogrel
JL Mega, SL Close, SD Wiviott, L Shen, RD Hockett, JT Brandt, JR Walker, ...
New England journal of medicine 360 (4), 354-362, 2009
31042009
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
29042005
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American …
GN Levine, ER Bates, JA Bittl, RG Brindis, SD Fihn, LA Fleisher, ...
Circulation 134 (10), e123-e155, 2016
28092016
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome …
TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich, MP Bonaca, ...
The Lancet 393 (10166), 31-39, 2019
25572019
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
21212015
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
JA De Lemos, DA Morrow, JH Bentley, T Omland, MS Sabatine, ...
New England Journal of Medicine 345 (14), 1014-1021, 2001
21032001
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
18582011
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
New England Journal of Medicine 372 (16), 1500-1509, 2015
16592015
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ...
Jama 304 (16), 1821-1830, 2010
13832010
Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis
MG Silverman, BA Ference, K Im, SD Wiviott, RP Giugliano, SM Grundy, ...
Jama 316 (12), 1289-1297, 2016
13212016
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in …
MS Sabatine, DA Morrow, KA Jablonski, MM Rice, JW Warnica, ...
Circulation 115 (12), 1528-1536, 2007
1137*2007
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20